{"id":"W3177460853","doi":"10.1016/j.jacc.2021.04.083","title":"Mortality Benefit of Rivaroxaban Plus Aspirin in Patients With Chronic Coronary or Peripheral Artery Disease","year":2021,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Peripheral Artery Disease Management","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":false,"ca_institutions":"Institut universitaire de cardiologie et de pneumologie de Québec; Université Laval; Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"Boehringer Ingelheim; Sanofi; GlaxoSmithKline; Janssen Pharmaceuticals; AstraZeneca; Bayer; Servier; Pfizer; Eli Lilly and Company","keywords":"Medicine; Aspirin; Hazard ratio; Internal medicine; Coronary artery disease; Kidney disease; Stroke (engine); Cardiology; Heart failure; Diabetes mellitus; Rivaroxaban; Confidence interval; Warfarin; Surgery; Atrial fibrillation","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001763778,0.0001672039,0.001100595,0.0001030601,0.00002671819,0.000002627263,0.0002338013,0.0000260638,0.0000638546],"category_scores_gemma":[0.00007365126,0.0001007508,0.000351264,0.0004221805,0.0004694888,0.00007389181,0.0001467663,0.0001968866,5.152178e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004123473,"about_ca_system_score_gemma":0.0009758248,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001423771,"about_ca_topic_score_gemma":0.00005312369,"domain_scores_codex":[0.9982259,0.0002376366,0.0006528285,0.0001837613,0.0004651422,0.0002347327],"domain_scores_gemma":[0.9982346,0.0000515421,0.0007168987,0.0005046361,0.0003201874,0.0001721057],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.006955108,0.0002526897,0.9839779,0.0001356714,0.0008637203,0.001668761,0.00002448061,0.004381055,0.0002408169,0.0000300224,0.0005340411,0.0009357237],"study_design_scores_gemma":[0.004232442,0.002083566,0.9916577,0.0002380279,0.0004552346,0.000195384,0.0001696526,0.00009259637,0.00004530049,0.00005115261,0.0006771976,0.0001018012],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9980242,0.0002334039,0.00004300503,0.0008446823,0.0001756272,0.0002993628,0.0001418445,0.000003759608,0.0002341381],"genre_scores_gemma":[0.998978,0.00005139425,0.0001884562,0.000393989,0.0001414872,0.000006777894,0.000007499493,0.00001736906,0.0002150189],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007679734,"threshold_uncertainty_score":0.4108498,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01223958816175236,"score_gpt":0.2563547939712405,"score_spread":0.2441152058094881,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}